VCEL
Vericel Corporation
NASDAQ · USHealthcareBiotechnology
$45.88-1.63%
Price as of Jul 20, 2026
VCEL valuation
Vericel Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 69.94x
- P/E 2026E
- 83.59x
- P/E 2027E
- 52.28x
- P/E 2028E
- 29.19x
- P/S forward
- 6.82x
Trailing multiples
- P/E TTM
- 106.95x
- PEG TTM
- 2.03x
- Price / book
- 6.58x
- Price / sales
- 8.02x
- Price / cash flow
- 37.98x
Enterprise value
- Enterprise value
- $2.3B
- EV / sales
- 7.85x
- EV / EBITDA
- 65.01x
- EV / EBIT
- 145.33x
- Market cap
- $2.3B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.